Terms: = Pancreatic cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Treatment
72 results:
1. Potential Added Value of
Chen S; Wang G; Wu L; Chen D; Fang K; Liu W; Xu B; Zhai YQ; Li M
BMC Gastroenterol; 2024 Jan; 24(1):37. PubMed ID: 38233765
[TBL] [Abstract] [Full Text] [Related]
2.
Li X; Lu N; Lin L; Chen Y; Yang S; Wang H; Liu X; Wu C; Xue X; Su X; Bai X; Liang T
J Nucl Med; 2024 Feb; 65(2):206-212. PubMed ID: 38176719
[TBL] [Abstract] [Full Text] [Related]
3. Prediction of
Mileva M; Marin G; Levillain H; Artigas C; Van Bogaert C; Marin C; Danieli R; Deleporte A; Picchia S; Stathopoulos K; Jungels C; Vanderlinden B; Paesmans M; Ameye L; Critchi G; Taraji-Schiltz L; Velghe C; Wimana Z; Bali M; Hendlisz A; Flamen P; Karfis I
J Nucl Med; 2024 Feb; 65(2):236-244. PubMed ID: 38164576
[TBL] [Abstract] [Full Text] [Related]
4. Mechanisms Behind the Pharmacological Application of Biochanin-A: A review.
Anuranjana PV; Beegum F; K P D; George KT; Viswanatha GL; Nayak PG; Kanwal A; Kishore A; Shenoy RR; Nandakumar K
F1000Res; 2023; 12():107. PubMed ID: 38106650
[TBL] [Abstract] [Full Text] [Related]
5.
Ma XK; Liu TL; Ren YN; Ma XP; Yao Y; Hou XG; Ding J; Wang F; Huang HF; Zhu H; Yang Z
Acta Pharmacol Sin; 2024 Feb; 45(2):436-448. PubMed ID: 37749238
[TBL] [Abstract] [Full Text] [Related]
6. Tumor Characterization by [
Rasinski P; Af Burén S; Holstensson M; Nilsson T; Loizou L; Tran TA; Sparrelid E; Löhr JM; Axelsson R
J Nucl Med; 2023 Aug; 64(8):1232-1237. PubMed ID: 37348917
[TBL] [Abstract] [Full Text] [Related]
7. [
Zhu Z; Cheng K; Yun Z; Zhang X; Hu X; Liu J; Wang F; Fu Z; Yue J
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3425-3438. PubMed ID: 37328622
[TBL] [Abstract] [Full Text] [Related]
8. Initial Evaluation of [
Watabe T; Naka S; Tatsumi M; Kamiya T; Kimura T; Shintani Y; Abe K; Miyake T; Shimazu K; Kobayashi S; Kurokawa Y; Eguchi H; Doki Y; Inohara H; Kato H; Mori Y; Cardinale J; Giesel FL
J Nucl Med; 2023 Aug; 64(8):1225-1231. PubMed ID: 37268427
[TBL] [Abstract] [Full Text] [Related]
9. Visualization research on ENT1/NIS dual-function gene therapy to reverse drug resistance mediated by MUC1 in GEM-resistant pancreatic cancer.
Xi Y; Chen H; Xi Y; Hai W; Qu Q; Zhang M; Li B
Nucl Med Biol; 2023; 120-121():108350. PubMed ID: 37229950
[TBL] [Abstract] [Full Text] [Related]
10. A nomogram for preoperative prediction of microvascular invasion in ruptured hepatocellular carcinoma.
Xia F; Zhang Q; Ndhlovu E; Zheng J; Gao H; Xia G
Eur J Gastroenterol Hepatol; 2023 May; 35(5):591-599. PubMed ID: 36966771
[TBL] [Abstract] [Full Text] [Related]
11. Underutilization of pretreatment fertility preservation counseling in reproductive-age women with gastrointestinal cancer.
Gudmundsdottir H; Glasgow AE; Bews KA; Ruddy KJ; Thiels CA; Shenoy CC
Eur J Surg Oncol; 2023 Mar; 49(3):667-672. PubMed ID: 36746735
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic value of preoperative [
Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Huo L; Li X
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1780-1791. PubMed ID: 36695823
[TBL] [Abstract] [Full Text] [Related]
13. Targeting proteostasis of the HEV replicase to combat infection in preclinical models.
Zhang F; Xu LD; Zhang Q; Wang A; Yu X; Liu S; Chen C; Wu S; Jin J; Lin A; Neculai D; Zhao B; Feng XH; Liang T; Xu P; Huang YW
J Hepatol; 2023 Apr; 78(4):704-716. PubMed ID: 36574921
[TBL] [Abstract] [Full Text] [Related]
14. Tumor-to-blood ratio for assessment of fibroblast activation protein receptor density in pancreatic cancer using [
Chen R; Yang X; Yu X; Zhou X; Ng YL; Zhao H; Li L; Huang G; Zhou Y; Liu J
Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):929-936. PubMed ID: 36334106
[TBL] [Abstract] [Full Text] [Related]
15. [
Guberina N; Kessler L; Pöttgen C; Guberina M; Metzenmacher M; Herrmann K; Mucha M; Rischpler C; Indenkämpen F; Siveke JT; Treckmann J; Umutlu L; Kasper S; Fendler WP; Stuschke M
Sci Rep; 2022 Sep; 12(1):16261. PubMed ID: 36171444
[TBL] [Abstract] [Full Text] [Related]
16. Liver metastases in pancreatic ductal adenocarcinoma: a predictive model based on CT texture analysis.
De Robertis R; Geraci L; Tomaiuolo L; Bortoli L; Beleù A; Malleo G; D'Onofrio M
Radiol Med; 2022 Oct; 127(10):1079-1084. PubMed ID: 36057929
[TBL] [Abstract] [Full Text] [Related]
17. A dual meta-learning framework based on idle data for enhancing segmentation of pancreatic cancer.
Li J; Qi L; Chen Q; Zhang YD; Qian X
Med Image Anal; 2022 May; 78():102342. PubMed ID: 35354108
[TBL] [Abstract] [Full Text] [Related]
18. Comparison of the diagnostic efficacy of
Zhang Z; Jia G; Pan G; Cao K; Yang Q; Meng H; Yang J; Zhang L; Wang T; Cheng C; Zuo C
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2877-2888. PubMed ID: 35243518
[TBL] [Abstract] [Full Text] [Related]
19. In Vitro and In Vivo Metabolism of a Novel Antimitochondrial cancer Metabolism Agent, CPI-613, in Rat and Human.
Reddy VB; Boteju L; Boteju A; Shen L; Kassahun K; Reddy N; Sheldon A; Luther S; Hu K
Drug Metab Dispos; 2022 Apr; 50(4):361-373. PubMed ID: 35086846
[TBL] [Abstract] [Full Text] [Related]
20. PET/CT helps to determine treatment duration in patients with resected as well as inoperable alveolar echinococcosis.
Husmann L; Muehlematter UJ; Grimm F; Ledergerber B; Messerli M; Kudura K; Gruenig H; Muellhaupt B; Hasse B; Huellner MW
Parasitol Int; 2021 Aug; 83():102356. PubMed ID: 33872794
[TBL] [Abstract] [Full Text] [Related]
[Next]
